Last updated: November 18, 2025
Sponsor: University of California, San Francisco
Overall Status: Completed
Phase
N/A
Condition
Insomnia
Asperger's Disorder
Autism
Treatment
SweetDreams
Clinical Study ID
NCT04452045
UL1TR001872
Ages 12-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
have poor sleep health
have a diagnosis of ASD
Exclusion
Exclusion Criteria:
any regular sleep medication use (this does not include occasional over the countersleep aid)
known sleep apnea
unstable major medical conditions (e.g. severe asthma, diabetes).
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: SweetDreams
Phase:
Study Start date:
September 01, 2020
Estimated Completion Date:
December 31, 2021
Study Description
Connect with a study center
University of California, San Francisco
Piedmont, California 94143
United StatesSite Not Available
University of California, San Francisco
San Francisco, California 94143
United StatesSite Not Available
University of California, San Francisco
San Francisco 5391959, California 5332921 94143
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.